Tactile Systems Technology logo
Tactile Systems Technology TCMD
$ 26.34 -1.66%

Annual report 2025
added 02-17-2026

report update icon

Tactile Systems Technology Balance Sheet 2011-2026 | TCMD

Annual Balance Sheet Tactile Systems Technology

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-75.4 M -39.8 M 1.44 M -2.37 M -26.5 M -6.18 M -20.1 M -24 M -30.7 M -7.06 M -5.4 M -6.52 M - -

Long Term Debt

- 16 M 18.4 M 20.9 M 23.4 M 19.4 M - - - - - 4 K 14 K - -

Long Term Debt Current

3.2 M 2.98 M 2.81 M 2.5 M 2.51 M 2.01 M 1.45 M - - - - - - - -

Total Non Current Liabilities

14.1 M 40.6 M 46.7 M 69.3 M 81.6 M 22.6 M 17.7 M 1.72 M 1.14 M 503 K 193 K 649 K 1.37 M - -

Total Current Liabilities

41 M 40.7 M 41.1 M 64.3 M 34.5 M 26.7 M 21.4 M 16.1 M 14.5 M 13.8 M - - - - -

Total Liabilities

55 M 81.3 M 87.8 M 134 M 116 M 49.3 M 39.2 M 17.8 M 15.7 M 14.3 M 9.7 M 6.84 M 7.02 M - -

Retained Earnings

54.9 M 35.9 M 18.9 M -9.62 M 8.24 M - 20.7 M 9.7 M 3.08 M -2.77 M -5.65 M -6.87 M -8.94 M - -

Total Assets

274 M 298 M 281 M 255 M 244 M 174 M 152 M 107 M 88.4 M 73.9 M 37 M 31.5 M 29.2 M - -

Cash and Cash Equivalents

83.4 M 94.4 M 61 M 21.9 M 28.2 M 47.9 M 22.8 M 20.1 M 24 M 30.7 M 7.06 M 5.42 M - - -

Book Value

219 M 217 M 194 M 121 M 128 M 125 M 113 M 89.3 M 72.8 M 59.6 M 27.3 M 24.7 M 22.2 M - -

Total Shareholders Equity

219 M 217 M 194 M 121 M 128 M 125 M 113 M 89.3 M 72.8 M 59.6 M -5.65 M -6.43 M - - -

All numbers in USD currency

Quarterly Balance Sheet Tactile Systems Technology

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- 14.4 M 15.2 M 16 M 27 M 27.8 M 28.5 M 18.4 M 19 M 47.5 M 48.3 M 20.9 M 21.5 M - 22.7 M 23.4 M 23.4 M 18.5 M 18.9 M 19.4 M 19.4 M 19.4 M 19.4 M 15.1 M 15.1 M 15.1 M 15.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

15 M 37.7 M 39.2 M 40.6 M 42.7 M 43.9 M 45.4 M 46.7 M 64.9 M 66.4 M 67.9 M 69.3 M 78.5 M - 77.8 M 81.6 M 86 M 22.3 M 22.2 M 22.6 M 22.6 M 22.6 M 22.6 M 17.7 M 17.7 M 17.7 M 17.7 M 1.72 M 1.72 M 1.72 M 1.72 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

54.2 M 78.1 M 74.6 M 81.3 M 79.8 M 78.1 M 78.6 M 87.8 M 110 M 115 M 119 M 134 M 134 M - 118 M 116 M 117 M 48.9 M 50.2 M 49.3 M 49.3 M 49.3 M 49.3 M 39.2 M 39.2 M 39.2 M 39.2 M 17.8 M 17.8 M 17.8 M 17.8 M 15.7 M 15.7 M 15.7 M 15.7 M 14.3 M 14.3 M 14.3 M 14.3 M 9.7 M 9.7 M 9.7 M - - - - - - - - - - - - - - - - -

Retained Earnings

44.3 M 36.1 M 32.9 M 35.9 M 26.1 M 21 M 16.7 M 18.9 M 10.7 M -11.6 M -11.5 M -9.62 M -14.2 M - -7.32 M 8.24 M 15.7 M 19.1 M 17.8 M 20.1 M 20.1 M 20.1 M 20.1 M 20.7 M 20.7 M 20.7 M 20.7 M 9.7 M 9.7 M 9.7 M 9.7 M 3.08 M 3.08 M 3.08 M 3.08 M -2.77 M -2.77 M -2.77 M -2.77 M -5.65 M -5.65 M -5.65 M - - - - - - - - - - - - - - - - -

Total Assets

259 M 273 M 280 M 298 M 288 M 279 M 272 M 281 M 293 M 274 M 276 M 255 M 249 M - 233 M 244 M 249 M 182 M 175 M 174 M 174 M 174 M 174 M 152 M 152 M 152 M 152 M 107 M 107 M 107 M 107 M 88.4 M 88.4 M 88.4 M 88.4 M 73.9 M 73.9 M 73.9 M 73.9 M 37 M 37 M 37 M - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

66 M 81.5 M 83.6 M 94.4 M 82.1 M 73.6 M 60.7 M 61 M 66 M 63.2 M 55 M 21.9 M 23.4 M 23.4 M 21.2 M 28.2 M 22.4 M 49 M 46.9 M 47.9 M 47.9 M 47.9 M 47.9 M 22.8 M 22.8 M 22.8 M 22.8 M 22.8 M 20.1 M 20.1 M 20.1 M 24 M 24 M 24 M 24 M 30.7 M 30.7 M 30.7 M 30.7 M 7.06 M 7.06 M 7.06 M - 5.42 M - - - 6.54 M - - - - - - - - - - -

Book Value

205 M 195 M 206 M 217 M 208 M 201 M 193 M 194 M 183 M 159 M 156 M 121 M 114 M - 115 M 128 M 132 M 133 M 125 M 125 M 125 M 125 M 125 M 113 M 113 M 113 M 113 M 89.3 M 89.3 M 89.3 M 89.3 M 72.8 M 72.8 M 72.8 M 72.8 M 59.6 M 59.6 M 59.6 M 59.6 M 27.3 M 27.3 M 27.3 M - - - - - - - - - - - - - - - - -

Total Shareholders Equity

205 M 195 M 206 M 217 M 208 M 201 M 193 M 194 M 183 M 159 M 156 M 121 M 114 M 114 M 115 M 128 M 132 M 133 M 125 M 125 M 125 M 125 M 125 M 113 M 113 M 113 M 113 M 89.3 M 89.3 M 89.3 M 89.3 M 72.8 M 72.8 M 72.8 M 72.8 M 59.6 M 59.6 M 59.6 M 59.6 M -5.65 M -5.65 M -5.65 M - -6.43 M - - - -7.11 M - - - - - - - - - - -

All numbers in USD currency

Balance Sheet is a fundamental financial report of Tactile Systems Technology, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Medical devices

Issuer Price % 24h Market Cap Country
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Xtant Medical Holdings Xtant Medical Holdings
XTNT
$ 0.55 -2.31 % $ 73.5 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
Zimmer Biomet Holdings Zimmer Biomet Holdings
ZBH
$ 88.57 -0.65 % $ 18 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Alphatec Holdings Alphatec Holdings
ATEC
$ 10.93 -5.12 % $ 1.64 B usaUSA
Conformis Conformis
CFMS
- - $ 16.4 M usaUSA
Accuray Incorporated Accuray Incorporated
ARAY
$ 0.4 4.21 % $ 41.1 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
$ 34.58 -5.62 % $ 1.07 B usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
NanoVibronix NanoVibronix
NAOV
- - $ 1.08 M usaUSA
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Neovasc Neovasc
NVCN
- - $ 111 M canadaCanada
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
$ 0.59 -1.18 % $ 32.1 M usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 2.15 -5.29 % $ 3.36 M usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
$ 79.34 -3.36 % $ 46.4 B usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 11.2 -1.84 % $ 1.51 B usaUSA
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
$ 15.52 -5.08 % $ 364 M usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
Ra Medical Systems Ra Medical Systems
RMED
- 10.0 % $ 610 K usaUSA
Myomo Myomo
MYO
$ 0.7 2.32 % $ 29.3 M usaUSA
Penumbra Penumbra
PEN
$ 335.1 -0.39 % $ 13 B usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
$ 50.13 -0.63 % $ 1.47 B usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
$ 1.17 -5.65 % $ 47.6 M usaUSA
Cutera Cutera
CUTR
- -10.19 % $ 1.99 M usaUSA
Eargo Eargo
EAR
- - $ 10.2 M usaUSA
NuVasive NuVasive
NUVA
- - $ 2.07 B usaUSA
Nevro Corp. Nevro Corp.
NVRO
- - $ 217 M usaUSA
Surgalign Holdings Surgalign Holdings
SRGA
- -32.98 % $ 1.68 M usaUSA
STRATA Skin Sciences STRATA Skin Sciences
SSKN
- - $ 6.6 M usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
AVITA Medical AVITA Medical
RCEL
$ 3.82 -1.04 % $ 106 M australiaAustralia
AxoGen AxoGen
AXGN
$ 31.28 -3.01 % $ 1.44 B usaUSA
Delcath Systems Delcath Systems
DCTH
$ 8.97 -1.75 % $ 321 M usaUSA